Patents by Inventor Mauricio Montano

Mauricio Montano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of fibrin-targeting immunotherapy to reduce Coronavirus pathogenesis
    Publication number: 20240059761
    Abstract: As described herein, anti-fibrin antibodies can reduce and treat the symptoms of Coronavirus infection, including CoV-ID-19 infection. Compositions and methods are described herein that include active agents such as anti-fibrin antibodies that can inhibit inflammation in the lung and other tissues. These methods and compositions can inhibit the binding of SARS-COV-2 or SARS-COV-1 spike protein to fibrin.
    Type: Application
    Filed: December 16, 2021
    Publication date: February 22, 2024
    Inventors: Katerina Akassoglou, Jae Kyu Ryu, Warner C. Greene, Mauricio Montano
  • Animal Model for SARS-CoV-2-Spike Induced Coagulopathy
    Publication number: 20220184233
    Abstract: Described herein is an animal model useful for identifying therapeutic agents that can inhibit the physiological effects or symptoms of COVID-19 infection, including the effects of the following on one or more organs of the animal: inflammation, oxidative stress, fibrin deposition, blood brain barrier breakdown, clotting, and vascular problems,
    Type: Application
    Filed: December 16, 2021
    Publication date: June 16, 2022
    Inventors: Katerina Akassoglou, Warner Greene, Jae Kyu Ryu, Mauricio Montano